Gimoti (Metoclopramide HCl) Patent Expiration, LOE Window & CMS Spending

Gimoti (Metoclopramide HCl) by Qol Medical: FDA Orange Book LOE 2038-11-17, 5 AB generics, $6.2M 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorQol Medical
FDA Application & PathwayN209388 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2038-11-17
Orange Book Patents (*PED Extensions)7 patents (0 *PED)
Active AB-Rated Generic Competitors5
2024 CMS Total Public Spend$6.2M
2024 Medicare Part D Spend$4.6M
2024 Medicaid Spend$1.7M
Reported Wholesale Price Change (CA SB 17)2 WAC filings (max 32.7% 2-yr change)